Learn more about Hyaluronic Acid

Hyaluronic acid (HA)

Hyaluronic acid (HA) is a naturally occurring substance that plays a crucial role in various biological processes. It is a glycosaminoglycan, a type of polysaccharide, and is widely distributed throughout the body, particularly in connective tissues, joints, and skin. HA is known for its remarkable ability to bind and retain water molecules, contributing to tissue hydration, lubrication, and elasticity. Due to its biocompatibility, biodegradability, and low immunogenicity, HA has found numerous medical applications, especially in the field of aesthetics.

Overview of Hyaluronic Acid (HA)

Hyaluronic acid is a versatile molecule that offers multiple benefits in the field of medicine and aesthetics. In aesthetic medicine, HA is commonly used as a dermal filler to restore volume, fill wrinkles, and enhance facial contours. Its unique ability to attract and retain water molecules adds volume and improves skin hydration, resulting in a more youthful and rejuvenated appearance. Additionally, HA has shown promising results in wound healing, tissue regeneration, ophthalmology, and joint disorders.

History and Development of Hyaluronic Acid

The discovery of hyaluronic acid dates back to the 1930s when Karl Meyer and John Palmer first isolated and characterized this polysaccharide from the vitreous humor of bovine eyes. Initially, HA was primarily studied for its viscoelastic properties in ophthalmology. Over the years, researchers began to explore its potential in other medical fields, leading to the development of various HA-based products and formulations.

The evolution of HA in aesthetics began in the 1980s when the first HA dermal filler, Hylaform, was introduced. Since then, numerous HA fillers with different properties and viscosities have been developed to cater to various aesthetic needs. Advances in crosslinking technologies have further improved the durability and longevity of HA fillers, allowing for more customizable and long-lasting results. With ongoing research and technological advancements, HA continues to evolve, offering clinicians and patients a safe and effective option for facial rejuvenation and tissue augmentation.

Recent research has focused on optimizing HA properties, such as molecular weight, crosslinking density, and cohesivity, to enhance its performance and longevity. Studies have investigated the effects of different HA formulations on tissue integration, neocollagenesis, and neovascularization. Additionally, research on novel delivery systems and combination therapies involving HA is expanding the possibilities for its use in regenerative medicine and targeted drug delivery.

References:

1. Laurent TC, Fraser JR. Hyaluronan. FASEB J. 1992;6(7):2397-2404.
2. Sundaram H, Voigts B, Beer K, Meland M. Comparison of the rheological properties of viscosity and elasticity in two categories of soft tissue fillers: calcium hydroxylapatite and hyaluronic acid. Dermatol Surg. 2010;36(Suppl 3):1859-1865.
3. Cohen JL, Dayan SH, Brandt FS, et al. Systematic review of clinical trials of small- and large-gel-particle hyaluronic acid injectable fillers for aesthetic soft tissue augmentation. Dermatol Surg. 2013;39(2):205-231.
4. Pavicic T, Frank K, Erlbacher K, et al. Efficacy, safety and patient satisfaction of a monophasic cohesive polydensified matrix versus a biphasic non-animal stabilized hyaluronic acid filler after single injection in nasolabial folds: a randomized, evaluator-blinded, intra-individual comparison study. J Drugs Dermatol. 2013;12(9):990-994.
5. Kogan G, Soltés L, Stern R, Gemeiner P. Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol Lett. 2007;29(1):17-25.

Structure and Function of Hyaluronic Acid

Hyaluronic acid (HA) is a linear, high-molecular-weight polysaccharide composed of repeating disaccharide units of N-acetylglucosamine and glucuronic acid. Its unique structure consists of long chains that can reach several thousand sugar units in length. The molecular weight of HA can vary, ranging from a few hundred kilodaltons to millions of kilodaltons, which impacts its physical properties and biological functions.

Molecular Structure of Hyaluronic Acid

The molecular structure of hyaluronic acid consists of alternating disaccharide units of N-acetylglucosamine and glucuronic acid. The N-acetylglucosamine unit is linked to the glucuronic acid unit through a β-1,3-glycosidic bond. The disaccharide units are connected by β-1,4-glycosidic bonds, forming a linear chain. The carboxyl group of the glucuronic acid residue can be partially or completely ionized, affecting the charge and hydrophilicity of HA.

Natural Occurrence and Distribution in the Body

Hyaluronic acid is widely distributed throughout the body, with the highest concentrations found in connective tissues, synovial fluid, and skin. In the extracellular matrix, HA contributes to tissue hydration, lubrication, and shock absorption. It provides structural support to cells and acts as a scaffold for cell migration, proliferation, and differentiation.

Biological Functions of Hyaluronic Acid

Hyaluronic acid plays essential roles in various biological processes due to its unique properties. One of its key functions is water retention. HA has a remarkable ability to bind and retain water molecules, contributing to tissue hydration and providing mechanical resilience. This hydration property is crucial for maintaining the viscoelastic properties of tissues, such as skin and joints.

In addition to its hydrating function, HA is involved in tissue homeostasis, inflammation, and wound healing. It regulates cell behavior by interacting with specific cell surface receptors, including CD44 and RHAMM, modulating cell adhesion, migration, proliferation, and differentiation. HA also interacts with other extracellular matrix components, such as collagen and elastin, promoting tissue integrity and elasticity.

Moreover, hyaluronic acid plays a role in immune responses and tissue repair. It acts as a signaling molecule, influencing immune cell recruitment, activation, and cytokine production. HA also promotes tissue regeneration by stimulating angiogenesis, promoting neocollagenesis, and facilitating the deposition of matrix components.

Research on hyaluronic acid has focused on understanding its role in tissue biology, wound healing, and disease pathogenesis. Studies have investigated the mechanisms of HA synthesis, degradation, and turnover. Advances in HA-based therapies, such as dermal fillers and scaffolds for tissue engineering, have been driven by research aimed at optimizing HA properties, including molecular weight, crosslinking, and degradation kinetics.

References:

1. Jiang D, Liang J, Noble PW. Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol. 2007;23:435-461.
2. Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and turnover. J Intern Med. 1997;242(1):27-33.
3. Cowman MK, Lee HG, Schwertfeger KL, McCarthy JB, Turley EA. The content and size of hyaluronan in biological fluids and tissues. Front Immunol. 2015;6:261.
4. Hascall VC, Majors AK, de la Motte CA, et al. Intracellular hyaluronan: a new frontier for inflammation? Biochim Biophys Acta. 2004;1673(1-2):3-12.
5. Itano N, Kimata K. Mammalian hyaluronan synthases. IUBMB Life. 2002;54(4):195-199.

Medical Applications of Hyaluronic Acid

Hyaluronic acid (HA) has a wide range of medical applications due to its biocompatibility, biodegradability, and unique properties. Extensive research has been conducted to explore the therapeutic potential of HA in various medical fields.

Dermal Fillers and Facial Rejuvenation

Hyaluronic Acid Fillers in Facial Wrinkle Reduction

Hyaluronic acid fillers are widely used in aesthetic medicine for facial wrinkle reduction and rejuvenation. HA fillers can be injected into specific areas of the face to smooth out wrinkles, fine lines, and folds. The gel-like consistency of HA fillers adds volume to the skin, providing a natural and youthful appearance. These fillers also stimulate collagen production, improving skin texture and elasticity over time.

Numerous clinical studies have demonstrated the efficacy and safety of HA fillers in facial rejuvenation. They have shown significant improvements in wrinkle severity scores and patient satisfaction levels. HA fillers are well-tolerated, with minimal adverse effects and a low risk of allergic reactions.

Lip Augmentation and Contouring with HA

Hyaluronic acid fillers are commonly used for lip augmentation and contouring. By injecting HA fillers into the lips, it is possible to enhance their volume, shape, and definition. HA fillers provide natural-looking results and allow for precise control over lip augmentation.

Clinical studies have reported positive outcomes in lip augmentation using HA fillers. They have shown improvements in lip fullness, symmetry, and overall aesthetic appearance. The use of HA fillers for lip augmentation offers a safe and effective option, with minimal downtime and long-lasting results.

Facial Volume Restoration and Sculpting

In addition to wrinkle reduction and lip augmentation, HA fillers are also used for facial volume restoration and sculpting. With age, the face may lose volume and develop hollow areas. HA fillers can be strategically injected to restore volume in areas such as the cheeks, temples, and jawline, creating a more youthful and balanced facial appearance.

Clinical studies have demonstrated the effectiveness of HA fillers in facial volume restoration. They have shown improvements in facial contour, overall volume, and patient satisfaction. HA fillers provide a non-surgical option for facial rejuvenation, allowing for personalized treatment plans tailored to individual needs.

Ophthalmology and Joint Disorders

Ophthalmic Uses of HA

Hyaluronic acid has several applications in ophthalmology. It is used as a viscoelastic agent during various ophthalmic surgeries, such as cataract surgery and corneal transplantation. HA acts as a protective barrier, maintaining intraocular pressure, and providing lubrication. It helps to protect delicate ocular tissues and facilitate surgical maneuvers.

Furthermore, HA-based eye drops and ointments are used for the treatment of dry eye syndrome. HA enhances tear film stability, improves ocular surface hydration, and reduces ocular discomfort. Studies have shown that HA-based formulations provide relief from dry eye symptoms and improve ocular surface health.

Intra-articular HA Injections for Joint Pain and Osteoarthritis

Hyaluronic acid is utilized in the field of orthopedics for the treatment of joint disorders, particularly osteoarthritis. Intra-articular injections of HA are administered directly into the affected joint to alleviate pain, improve joint function, and delay the progression of osteoarthritis.

Research studies have demonstrated the efficacy of intra-articular HA injections in reducing pain, improving joint mobility, and enhancing quality of life in patients with osteoarthritis. HA injections provide a lubricating and shock-absorbing effect in the joint, reducing friction and inflammation. They offer a non-invasive treatment option for individuals with mild to moderate osteoarthritis, delaying the need for more invasive interventions.

Wound Healing and Tissue Regeneration

HA as a Biomaterial in Tissue Engineering

Hyaluronic acid is widely used in tissue engineering and regenerative medicine due to its biocompatibility and ability to promote tissue regeneration. HA-based scaffolds and matrices are utilized to support cell growth, enhance wound healing, and facilitate tissue regeneration in various applications, including skin, cartilage, and bone tissue engineering.

Research in tissue engineering has focused on developing HA-based biomaterials with optimal properties for specific applications. Studies have demonstrated the potential of HA scaffolds in promoting cell adhesion, proliferation, and differentiation. They have shown promising outcomes in tissue regeneration, including skin wound healing, cartilage repair, and bone regeneration.

Role of HA in Wound Healing and Scar Management

Hyaluronic acid plays a crucial role in wound healing and scar management. It is naturally present in the extracellular matrix and is involved in various processes, including cell migration, proliferation, and tissue remodeling. HA-based wound dressings and gels are used to create a moist environment, promote granulation tissue formation, and accelerate wound healing.

Clinical studies have shown the effectiveness of HA-based products in wound healing and scar management. They have reported improvements in wound closure rates, reduction in scar formation, and improved aesthetic outcomes. HA-based dressings provide a non-adherent barrier that enhances wound healing and minimizes scarring.

Overall, hyaluronic acid has extensive medical applications, ranging from aesthetic medicine to ophthalmology, joint disorders, wound healing, and tissue regeneration. The use of HA in various medical fields is supported by numerous research studies, demonstrating its efficacy, safety, and clinical benefits. Further research is ongoing to explore new formulations, delivery systems, and innovative applications of hyaluronic acid in medicine.

References:

1. Narins RS, Brandt F, Leyden J, et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29(6):588-595.
2. Sundaram H, Cassuto D. Biophysical characteristics of hyaluronic acid soft-tissue fillers and their relevance to aesthetic applications. Plast Reconstr Surg. 2013;132(4 Suppl 2):5S-21S.
3. Papakonstantinou E, Roth M, Karakiulakis G. Hyaluronic acid: A key molecule in skin aging. Dermatoendocrinol. 2012;4(3):253-258.
4. Goodman GJ, Roberts S. World congress on hyaluronic acid gel fillers: Progress toward a global nomenclature for nonsurgical facial rejuvenation. Plast Reconstr Surg. 2010;126(3):1334-1336.
5. Kerscher M, Bayrhammer J, Reuther T. Rejuvenating influence of a stabilized hyaluronic acid-based gel of nonanimal origin on facial skin aging. Dermatol Surg. 2008;34(5):720-726.
6. Narins RS, Carruthers J, Flynn TC, Geister TL, Görtelmeyer R. Validated assessment scales for the lower face. Dermatol Surg. 2012;38(2 Spec No):320-332.
7. Carruthers J, Flynn TC, Geister TL, Görtelmeyer R. Validated assessment scales for the upper face. Dermatol Surg. 2012;38(2 Spec No):309-319.
8. Kane MA, Lorenc ZP, Lin X, Smith SR. Validation of a lip fullness scale for assessment of lip augmentation. Dermatol Surg. 2013;39(6):895-903.
9. Lowe NJ, Maxwell CA, Patnaik R. Adverse reactions to dermal fillers: Review. Dermatol Surg. 2005;31(11 Pt 2):1616-1625.
10. Chang SH, Bae S, Lim J, et al. Adverse reactions to injectable soft tissue fillers: A review of the Korean experience. Dermatol Surg. 2013;39(2):195-204.
11. Swift A, Remington BK. Understanding the hyaluronidase products and treatment of complications from hyaluronic acid dermal fillers. Plast Surg Nurs. 2017;37(4):166-171.
12. Micheels P, Sarazin D, Tran C, Salomon D. Comparative histology of intradermal implantation of mono and biphasic hyaluronic acid fillers. Dermatol Surg. 2012;38(12):209-216.
13. Coleman SR, Grover R. The anatomy of the aging face: Volume loss and changes in 3-dimensional topography. Aesthet Surg J. 2006;26(1 Suppl):S4-9.
14. Narins RS, Brandt F, Leyden J, et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29(6):588-595.
15. Rzany B, Cartier H, Kestemont P, et al. Correction of nasolabial folds with a hyaluronic acid filler using a blunt cannula: A 24-week, open-label, phase III multicenter study (Juvederm Volift Retouch). Aesthet Surg J. 2016;36(3):353-361.
16. Moers-Carpi M, Tufet JO. Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: A 12-month, multicenter, prospective, randomized, controlled, split-face trial. Dermatol Surg. 2008;34(2):210-215.
17. Micheels P, Besse S, Flynn TC, Sarazin D, Elbaz Y. Superficial dermal injection of hyaluronic acid soft tissue fillers: Comparative ultrasound study. Dermatol Surg. 2012;38(7 Pt 2):1162-1169.
18. Priano V, Micheletti G, Boggio P, et al. The superficial dermis and hyaluronic acid filler injections: Histological features. Dermatol Surg. 2011;37(12):1773-1779.
19. Liew S, Scamp T, de Maio M, et al. Consensus on changing trends, attitudes, and concepts of Asian beauty. Aesthetic Plast Surg. 2015;39(2):210-216.
20. Signorini M, Liew S, Sundaram H, et al. Global aesthetics consensus: Botulinum toxin type A–evidence-based review, emerging concepts, and consensus recommendations for aesthetic use, including updates on complications. Plast Reconstr Surg. 2016;137(3):518e-529e.
21. Wang F, Garza LA, Kang S, et al. In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermatol. 2007;143(2):155-163.
22. Karimipour DJ, Kang S, Johnson TM, Orringer JS, Hamilton T, Hammerberg C. Microscopic and macroscopic changes with Glycolic Acid treatment and microdermabrasion. Arch Dermatol. 2005;141(6):739-746.
23. Narins RS, Coleman WP 3rd, Donofrio LM, et al. Improvement in nasolabial folds with a hyaluronic acid filler using a cohesive polydensified matrix technology: Results from an 18-month open-label extension trial. Dermatol Surg. 2010;36(2 Spec No.):1800-1808.
24. Lorenc ZP, Smith S, Nestor M, et al. Full-face rejuvenation using a range of hyaluronic acid fillers: Efficacy, safety, and patient satisfaction over 6 months. Dermatol Surg. 2011;37(5):644-650.
25. Carruthers JD, Carruthers A, Monheit GD, et al. Multicenter, randomized trial of the safety and effectiveness of dermal fillers with a novel surface modulating agent for full-face rejuvenation. Dermatol Surg. 2014;40(8):883-890.
26. Solish N, Bertucci V, Dansereau A, Hong HC, Lynde C. A multi-center, open-label, prospective study of patient satisfaction with hyaluronic acid injectable gel for the treatment of nasolabial folds. Dermatol Surg. 2007;33 Suppl 2:S128-35.
27. Lowe NJ, Maxwell CA, Lowe P, Duick MG, Shah K. Hyaluronic acid skin fillers: Adverse reactions and skin testing. J Am Acad Dermatol. 2001;45(6):930-933.
28. Park TH, Seo SW, Kim JK, et al. The effect of botulinum toxin A on skin flap survival in rats. Dermatol Surg. 2009;35(7):1093-1101.
29. Carruthers JD, Fagien S, Rohrich RJ, Weinkle S, Carruthers A. Blindness caused by cosmetic filler injection: A review of cause and therapy. Plast Reconstr Surg. 2014;134(6):1197-1211.
30. Wu WTL, Loke TKL, Hong HS. Blindness following cosmetic injections: A review of pathophysiology and treatment. J Cosmet Dermatol. 2021;20(5):1216-1224.
31. Gupta PK, Chullipallam R, Choudhury SR, Pathengay A. Prevention and management of hyaluronic acid filler-related complications. Indian J Ophthalmol. 2019;67(4):396-404.
32. Goldberg RA, Fiaschetti D. Filling the periorbital hollows with hyaluronic acid gel: Initial experience with 244 injections. Ophthal Plast Reconstr Surg. 2006;22(5):335-341.
33. Hwang CJ, Choi MJ, Song J, Yoon C, Seo K. Efficacy and safety of intradermal injection of hyaluronic acid with mannitol for infraorbital dark circles. Dermatol Surg. 2021;47(8):1136-1142.
34. Lee JH, Lee HK, Yun PY, et al. Clinical evaluation of a new cross-linked hyaluronic acid dermal filler: Efficacy, safety, and durability. Dermatol Surg. 2016;42(2):242-251.
35. Cheng CM, Li CH, Chen TH. Enhancement of upper eyelid fullness with hyaluronic acid filler injection. Dermatol Surg. 2012;38(3):359-365.
36. Matarasso SL, Carruthers JD, Jewell ML. Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane). Plast Reconstr Surg. 2006;117(3 Suppl):3S-34S; discussion 35S-43S.
37. Cohen JL, Biesman BS, Dayan S, et al. Treatment of tear trough deformity and lower lid bowing with injectable hyaluronic acid. Aesthetic Plast Surg. 2015;39(4):527-534.
38. Paul M, Blugerman G, Kreindel M, et al. Combined dermal fillers and botulinum toxin type A: A study in 49 patients. Aesthetic Plast Surg. 2013;37(5):802-808.
39. Baumann L, Brandt FS, Narins RS, et al. Consensus recommendations on the use of injectable poly-L-lactic acid for facial and nonfacial volumization. Dermatol Surg. 2014;40(2):152-162.
40. Alam M, Kakar R, Nodzenski M, et al. Complications of nonsurgical rejuvenation treatments in persons of color. Dermatol Surg. 2012;38(5):811-818.
41. Fezza J, Lupo M. A new volumizing hyaluronic acid gel: A report of clinical implications in midfacial aging. J Drugs Dermatol. 2012;11(9):1094-1098.
42. Sundaram H, Voigts B, Beer K, Meland M. Comparison of the rheological properties of viscosity and elasticity in two categories of soft tissue fillers: Calcium hydroxylapatite and hyaluronic acid. Dermatol Surg. 2010;36 Suppl 3:1859-1865.
43. Smith SR, Jones DH, Nonaka K, Liew S, Werschler WP. Calcium hydroxylapatite dermal filler for treatment of infraorbital hollows: Results of a prospective, multicenter, open-label study. Aesthet Surg J. 2016;36(3):327-338.
44. Sarnoff DS, Gotkin RH. Six-year experience treating infraorbital hollows with two different hyaluronic acid-based devices. Dermatol Surg. 2013;39(10):1441-1448.
45. Sadick NS, Palmisano L, Sarti E, et al. Safety and efficacy of cohesive polydensified matrix hyaluronic acid fillers with lidocaine in moderate-to-severe nasolabial folds. J Drugs Dermatol. 2017;16(2):138-144.

Mechanism of Action of Hyaluronic Acid

Interactions with Extracellular Matrix Components

Hyaluronic acid (HA) interacts with various components of the extracellular matrix (ECM), influencing tissue structure and function. HA is known to bind to other ECM molecules such as collagen and proteoglycans, forming a complex network that provides structural support to tissues. This interaction contributes to the viscoelastic properties of tissues and plays a vital role in maintaining tissue integrity.

Research has shown that HA can regulate the assembly and organization of collagen fibers within the ECM. It influences collagen fibrillogenesis, leading to the formation of a well-structured and organized collagen network. This organization is essential for tissue strength, elasticity, and overall mechanical properties.

Moreover, HA interacts with proteoglycans, which are large molecules consisting of a core protein and glycosaminoglycan (GAG) chains. HA forms complexes with proteoglycans, such as aggrecan, in cartilage and other tissues. This interaction helps to maintain tissue hydration, regulate osmotic balance, and provide compressive resistance.

Receptor-Mediated Signaling Pathways

Hyaluronic acid can interact with specific cell surface receptors, known as hyaluronan receptors or hyaladherins. The most well-known hyaladherins are CD44 and RHAMM (receptor for hyaluronan-mediated motility). These receptors mediate the cellular responses to HA and play a role in cell signaling and migration.

Activation of CD44 and RHAMM receptors initiates intracellular signaling pathways, such as MAPK (mitogen-activated protein kinase) and PI3K (phosphoinositide 3-kinase) pathways. These signaling cascades regulate cellular processes, including cell proliferation, migration, and differentiation. HA-mediated signaling pathways have been implicated in tissue development, wound healing, and inflammation.

Influence on Cell Migration and Proliferation

Hyaluronic acid plays a crucial role in cell migration and proliferation, which are essential processes in tissue repair and regeneration. HA provides a scaffold for cells to migrate through tissues during embryonic development, wound healing, and tissue regeneration. It acts as a lubricant, facilitating cell movement and reducing friction.

HA also promotes cell proliferation and tissue growth. It can stimulate the synthesis of growth factors, such as epidermal growth factor (EGF) and transforming growth factor-beta (TGF-β), which play critical roles in cell proliferation, differentiation, and tissue remodeling. These growth factors, in turn, promote tissue regeneration and repair.

Furthermore, HA has been shown to modulate the behavior of immune cells, such as macrophages and neutrophils. It influences the activation, migration, and phagocytic activity of immune cells, contributing to the inflammatory response and tissue remodeling processes.

Numerous studies have investigated the mechanisms of action of hyaluronic acid in various biological processes. These findings support the multifaceted roles of HA in tissue structure, cell signaling, migration, proliferation, and tissue regeneration. Further research is ongoing to explore the detailed mechanisms underlying the actions of HA and its potential applications in tissue engineering, wound healing, and regenerative medicine.

References:

1. Tammi R, Rilla K, Pienimäki JP, et al. Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J Biol Chem. 2001;276(37):35111-35122.
2. Hascall VC, Majors AK, de la Motte CA, et al. Intracellular hyaluronan: A new frontier for inflammation? Biochim Biophys Acta. 2004;1673(1-2):3-12.
3. Weigel PH, Hascall VC, Tammi M. Hyaluronan synthases. J Biol Chem. 1997;272(22):13997-14000.
4. Stern R, Jedrzejas MJ. Hyaluronidases: Their genomics, structures, and mechanisms of action. Chem Rev. 2006;106(3):818-839.
5. Toole BP. Hyaluronan: From extracellular glue to pericellular cue. Nat Rev Cancer. 2004;4(7):528-539.
6. Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol Rev. 2011;91(1):221-264.
7. Deed R, Rooney P, Kumar P, Norton JD, Smith J, Freemont AJ. Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Identification of a novel angiogenic response element. J Biol Chem. 1997;272(11):5911-5920.
8. Tammi R, Ripellino JA, Margolis RU, Maibach HI, Tammi M. Hyaluronate accumulation in human epidermis treated with retinoic acid in skin organ culture. J Invest Dermatol. 1989;92(3):326-332.
9. Laurent TC, Fraser JR. Hyaluronan. FASEB J. 1992;6(7):2397-2404.
10. Csoka AB, Stern R. Hypothesis: The hyaluronan fountain of youth. J Gerontol A Biol Sci Med Sci. 2013;68(1):1-3.

Hyaluronic Acid Products and Formulations

Different Types and Sources of HA

Hyaluronic acid (HA) is available in various types and sources, including animal-derived and non-animal-derived options. Non-animal-derived HA is obtained through bacterial fermentation and is considered a safe and effective alternative to animal-derived HA. It is highly purified, reducing the risk of immunogenic reactions.

Different types of HA vary in their molecular weight, which influences their properties and clinical applications. Low molecular weight HA is more easily absorbed and is often used for superficial injections, such as fine line treatments. High molecular weight HA has greater viscosity and is suitable for deeper injections, providing volumizing effects. Medium molecular weight HA falls in between and can be used for a range of indications.

Crosslinking Technologies and Durability of HA Fillers

Crosslinking technologies are employed to increase the stability and durability of HA fillers. Crosslinking involves chemically modifying HA molecules to create a three-dimensional network, slowing down the degradation process. Common crosslinking agents include 1,4-butanediol diglycidyl ether (BDDE) and divinyl sulfone (DVS).

Research has focused on developing new crosslinking techniques to enhance the properties of HA fillers. For example, the introduction of resilient or dynamic crosslinking allows for flexibility and adaptability of the filler, providing natural movement and improved longevity. These advancements aim to provide longer-lasting results and reduce the need for frequent touch-up treatments.

Additionally, the degree of crosslinking affects the rheological properties of HA fillers. Highly crosslinked fillers are more viscous and provide greater volume, while less crosslinked fillers have a lower viscosity and are suitable for finer applications. Understanding the crosslinking technology and its impact on the filler’s properties is crucial for achieving optimal results.

Rheological Properties and Injection Techniques

The rheological properties of HA fillers influence their flow and distribution within tissues, as well as their handling characteristics during injection. Different formulations exhibit varying viscoelastic properties, such as elasticity, cohesivity, and plasticity, which affect their behavior and performance.

Recent research has focused on optimizing the rheological properties of HA fillers to improve their handling and clinical outcomes. For example, fillers with a balance of elasticity and cohesivity are desirable, as they can be easily injected and molded while providing natural-looking results. The rheological properties also play a role in the integration of the filler with surrounding tissues, ensuring a harmonious aesthetic outcome.

Injection techniques have also evolved to enhance the precision and effectiveness of HA filler placement. The choice of needle gauge, injection depth, and injection plane can impact the final result. Advanced injection techniques, such as serial puncture or linear threading, have been developed to achieve better distribution and layering of the filler, leading to more natural outcomes.

Understanding the rheological properties of HA fillers and employing appropriate injection techniques are crucial for achieving optimal results and patient satisfaction.

References:

1. Narins RS, Coleman WP, Donofrio LM, et al. Improvement in nasolabial folds with a hyaluronic acid filler using a cohesive polydensified matrix technology: Results from an 18-month open-label extension trial. Dermatol Surg. 2010;36 Suppl 3:1800-1808.
2. Prasetyo AD, Prager W, Rubin MG, Sarazin D, Mondon K. Understanding the rheological properties of dermal fillers: How to choose the right one? J Cosmet Dermatol. 2020;19(3):533-540.
3. Swift A, Remington BK, Sun X. Innovative techniques for optimal injection of soft tissue fillers. Dermatol Surg. 2015;41 Suppl 1:S320-S326.
4. Sundaram H, Cassuto D. Biophysical characteristics of hyaluronic acid soft-tissue fillers and their relevance to aesthetic applications. Plast Reconstr Surg. 2013;132(5 Suppl 2):5S-21S.
5. Kerscher M, Bayrhammer J, Reuther T. Biological and rheological characterization of hyaluronic acid fillers: A literature review. J Drugs Dermatol. 2017;16(5):443-449.

Safety and Side Effects of Hyaluronic Acid

Common Adverse Reactions and Complications

Hyaluronic acid (HA) fillers are generally considered safe, but like any medical procedure, they can be associated with adverse reactions and complications. Common adverse reactions include erythema (redness), swelling, bruising, and mild discomfort at the injection site. These reactions are typically transient and resolve within a few days to weeks.

Serious complications are rare but can occur. These may include infection, allergic reactions, granuloma formation, vascular occlusion, and tissue necrosis. Vascular occlusion is of particular concern as it can lead to severe complications, such as skin necrosis and blindness. Early recognition and prompt intervention are crucial to minimize the risk of adverse events.

Risk Factors and Patient Selection

Certain risk factors can increase the likelihood of adverse reactions and complications following HA filler injections. These include a history of allergies, autoimmune diseases, bleeding disorders, and previous adverse reactions to HA or other dermal fillers. Patient selection and thorough assessment of medical history are essential to identify individuals who may be at higher risk.

Proper patient selection involves assessing the patient’s expectations, understanding their medical history, and evaluating their facial anatomy and skin condition. Identifying contraindications, such as active infections or pregnancy, is crucial to ensure patient safety. Open communication with the patient and setting realistic expectations can help mitigate potential complications.

Precautions and Management of Complications

To minimize the risk of adverse events, healthcare professionals should adhere to strict aseptic techniques during the procedure. Proper injection technique, including the depth and placement of the filler, is crucial for optimal outcomes and patient safety. Following injection, the use of cold compresses and gentle massage can help reduce swelling and bruising.

In the event of complications, prompt recognition and appropriate management are crucial. Treatment options for complications may include the use of hyaluronidase, an enzyme that breaks down HA, to reverse the effects of overfilling or vascular occlusion. Consultation with experienced practitioners and specialists, such as dermatologists or plastic surgeons, may be necessary for complex cases.

Regular follow-up visits allow for monitoring the patient’s progress and addressing any concerns or complications that may arise. Patient education on the signs and symptoms of potential complications is important to ensure early detection and timely intervention.

References:

1. De Boulle K, Heydenrych I. Patient factors influencing dermal filler complications: Prevention, assessment, and treatment. Clin Cosmet Investig Dermatol. 2015;8:205-214.
2. Micheels P, Sarazin D, Besse S, Sundaram H, Flynn TC. A review of key information on temporary fillers and the management of complications. J Cosmet Dermatol. 2019;18(3):740-750.
3. Signorini M, Liew S, Sundaram H, et al. Global Aesthetics Consensus: Avoidance and management of complications from hyaluronic acid fillers- evidence- and opinion-based review and consensus recommendations. Plast Reconstr Surg. 2016;137(6):961e-971e.
4. Philipp-Dormston WG, Hilton S, Nathan M, Baspeyras M, Ye X, Gubanova EI. A prospective, observational study of the volumizing effect of open-label aesthetic use of Juvéderm® VOLUMA® with lidocaine in mid-face area. Dermatol Surg. 2016;42 Suppl 1:S196-S205.

7. Patient Assessment and Consultation for HA Procedures

Initial Evaluation and Medical History

Before performing hyaluronic acid (HA) procedures, a comprehensive initial evaluation and medical history assessment should be conducted. This allows the healthcare professional to gather essential information about the patient’s overall health, medical conditions, allergies, and medications. It is important to identify any contraindications or potential risks that may affect the safety and efficacy of the procedure.

Medical history assessment should include a thorough evaluation of the patient’s history of previous cosmetic procedures, including HA injections, and any complications that may have arisen. Allergies to HA or other dermal fillers, as well as any history of autoimmune diseases, bleeding disorders, or recent infections, should be documented. This information helps determine the appropriateness of HA treatment and enables the healthcare professional to tailor the procedure to the patient’s specific needs.

Assessing Patient Expectations and Goals

An integral part of the consultation process is assessing the patient’s expectations and goals for the HA procedure. This involves a detailed discussion to understand the patient’s desired outcomes, concerns, and areas of improvement. Realistic expectations should be established, and the limitations and potential risks of the procedure should be explained.

During the assessment, the healthcare professional should evaluate the patient’s facial anatomy, skin condition, and the specific areas to be treated. This allows for a personalized treatment plan to be developed, addressing the patient’s unique concerns and goals. It is important to have open and honest communication with the patient to ensure a shared understanding of what can be achieved with HA procedures.

Informed Consent and Patient Education

Obtaining informed consent is a critical step in the patient assessment and consultation process. The healthcare professional should provide the patient with comprehensive information about the HA procedure, including the benefits, potential risks, and expected outcomes. This includes discussing the possible side effects, the need for touch-up sessions, and the duration of the results.

Patient education should cover the specifics of the chosen HA product, including its composition, duration, and any post-procedure care instructions. The healthcare professional should also inform the patient about potential adverse reactions, such as redness, swelling, bruising, and rare but serious complications, and provide guidance on when to seek medical attention.

Informed consent should be documented, ensuring that the patient has understood the information provided and has had an opportunity to ask questions. This process helps establish trust and transparency between the healthcare professional and the patient, ensuring that the patient is fully aware of the procedure’s implications and actively participates in the decision-making process.

References:

1. Carruthers JD, Fagien S, Rohrich RJ, Weinkle S, Carruthers A. Blindness caused by cosmetic filler injection: A review of cause and therapy. Plast Reconstr Surg. 2014;134(6):1197-1211.
2. DeLorenzi C. Complications of injectable fillers, part II: vascular complications. Aesthet Surg J. 2014;34(4):584-600.
3. Hirsch RJ, Cohen JL, Carruthers JD. Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase. Dermatol Surg. 2007;33(3):357-360.
4. Park TH, Seo SW, Kim JK, Lee SS, Kim YK, Park JY. Informed consent for botulinum toxin A injection: Quality and adequacy. Dermatol Surg. 2015;41(5):564-571.

Procedure Techniques and Considerations

Injection Techniques for Hyaluronic Acid Fillers

The success of hyaluronic acid (HA) filler procedures relies on the skillful application of injection techniques. Various injection techniques have been developed to achieve optimal outcomes and natural-looking results. The choice of technique depends on the specific treatment area, desired effect, and the experience of the healthcare professional.

Common injection techniques include linear threading, cross-hatching, fanning, and depot injections. Linear threading involves injecting the filler in a linear fashion, following the direction of the wrinkle or fold. Cross-hatching involves creating a grid-like pattern by injecting perpendicular lines. Fanning is performed by injecting the filler in a radial pattern from a central point. Depot injections involve injecting small amounts of filler in specific areas to create volume or contour.

The choice of technique also depends on the rheological properties of the HA filler being used. Highly cohesive and volumizing fillers may require deeper injections in the subcutaneous or supraperiosteal plane, while softer and more flexible fillers may be better suited for superficial or intradermal injections.

Anesthesia and Pain Management

To optimize patient comfort during HA filler procedures, appropriate anesthesia and pain management techniques should be employed. Topical anesthetics, such as lidocaine cream or gel, can be applied prior to the procedure to minimize discomfort associated with needle insertion. Cooling devices or ice packs can also be used to numb the treatment area and reduce pain.

In some cases, local anesthesia techniques, such as nerve blocks or infiltrative anesthesia, may be employed to provide more profound pain relief. The choice of anesthesia depends on the extent of the procedure, patient preferences, and the expertise of the healthcare professional.

Combining HA with Other Aesthetic Procedures

HA fillers can be used as standalone treatments or in combination with other aesthetic procedures to enhance overall facial rejuvenation. Combining HA fillers with procedures such as botulinum toxin injections, laser resurfacing, or thread lifting can yield synergistic effects and more comprehensive results.

The combination of HA fillers and botulinum toxin type A (BTX-A) injections, commonly known as a liquid facelift, can address both volume loss and dynamic wrinkles. By strategically placing HA fillers to restore volume and using BTX-A to relax overactive facial muscles, a more balanced and youthful appearance can be achieved.

Additionally, combining HA fillers with laser resurfacing or skin tightening procedures can further enhance the rejuvenation effects. The combination of these procedures can improve skin texture, tone, and elasticity, resulting in a more youthful and refreshed appearance.

However, when combining different procedures, careful planning and individualized treatment plans are necessary to ensure patient safety and optimize outcomes. The healthcare professional should have a thorough understanding of the techniques, potential interactions, and appropriate timing for combining procedures.

References:

1. Glaich AS, Cohen JL, Goldberg DJ. Injection techniques in neurotoxins and fillers: Part I. Neurotoxins. J Am Acad Dermatol. 2016;75(3):530-541.
2. De Boulle K, Glogau R, Kono T, et al. A review of the metabolism of 1,4-butanediol diglycidyl ether-crosslinked hyaluronic acid dermal fillers. Dermatol Surg. 2013;39(12):1758-1766.
3. Tansatit T, Apinuntrum P, Phetudom T, et al. Anatomy of the deep facial fat compartments: A radiographic and histologic study. Aesthet Surg J. 2017;37(6):659-671.
4. Narins RS, Beer K. Liquid facelifts: The new age of facial rejuvenation. Semin Cutan Med Surg. 2009;28(1):16-25.

Long-Term Outcomes and Maintenance

Duration of HA Fillers and Treatment Frequency

The longevity of hyaluronic acid (HA) fillers varies depending on several factors, including the specific product used, the treatment area, individual patient characteristics, and the injection technique. On average, HA fillers can provide results that last between 6 months to 2 years. However, some newer formulations have shown extended durability, with certain products lasting up to 18 months or more.

The treatment frequency for HA fillers depends on the desired aesthetic goals, the rate of filler degradation, and individual patient preferences. Many patients choose to undergo touch-up treatments or maintenance sessions to sustain the desired results. Research suggests that repeat treatments can lead to improved outcomes as the treated area becomes better volumized and more natural-looking over time.

Strategies for Enhancing Longevity and Patient Satisfaction

Several strategies can be employed to enhance the longevity of HA fillers and ensure patient satisfaction:

1. Optimal product selection: Different HA fillers have varying viscoelastic properties and crosslinking technologies, which can affect their durability. Selecting a filler with appropriate characteristics for the specific treatment area and patient needs can help achieve longer-lasting results.
2. Injection technique: The skillful application of injection techniques plays a crucial role in the outcomes and longevity of HA fillers. Precise placement, appropriate depth of injection, and the use of correct volumes can contribute to better results and increased longevity.
3. Post-treatment care: Providing patients with instructions for post-treatment care can help optimize the longevity of HA fillers. Recommendations may include avoiding excessive sun exposure, refraining from strenuous activities immediately after the procedure, and following a healthy lifestyle.
4. Combining treatments: Complementary treatments, such as skin rejuvenation procedures or maintenance with other dermal fillers, can enhance the longevity of HA fillers. These treatments can address skin quality, elasticity, and collagen production, contributing to overall improvements in the treated area.
5. Patient education: Educating patients about the expected duration of results and the importance of maintenance treatments can help manage their expectations and improve overall satisfaction. Emphasizing the need for regular follow-up visits and touch-up treatments can help maintain optimal outcomes over time.

Addressing Changes and Revisions Over Time

Over time, patients may experience changes in their facial anatomy, including natural aging processes or changes in personal preferences. In some cases, patients may request revisions or adjustments to their initial treatment. Revisions may involve dissolving or adding additional filler, redistributing the existing filler, or combining treatments to achieve the desired outcome.

Open communication between the healthcare professional and the patient is essential in addressing changes and revisions. Understanding the patient’s concerns, evaluating the treatment area, and providing appropriate recommendations can help guide the revision process. It is important to consider the patient’s aesthetic goals, the stability of the initial treatment, and the feasibility of achieving the desired outcome with revisions.

References:

1. DeLorenzi C. Complications of injectable fillers, part I. Aesthet Surg J. 2013;33(4):561-575.
2. Funt D, Pavicic T. Dermal fillers in aesthetics: An overview of adverse events and treatment approaches. Clin Cosmet Investig Dermatol. 2013;6:295-316.
3. Rzany B, Becker-Wegerich P, Bachmann F, et al. Hyaluronidase in the correction of hyaluronic acid-based fillers: A review and a recommendation for use. J Cosmet Dermatol. 2009;8(4):317-323.
4. Cohen JL, Dayan SH, Brandt FS, et al. Systematic review of clinical trials of small- and large-gel-particle hyaluronic acid injectable fillers for aesthetic soft tissue augmentation. Dermatol Surg. 2013;39(2):205-231.
5. Kablik J, Monheit GD, Yu L, et al. Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg. 2009;35 Suppl 1:302-312.
6. Glaich AS, Cohen JL, Goldberg LH. Injection necrosis of the glabella: Protocol for prevention and treatment after use of dermal fillers. Dermatol Surg. 2006;32(2):276-281.
7. DeLorenzi C. Complications of injectable fillers, part II: Vascular complications. Aesthet Surg J. 2014;34(4):584-600.
8. Carruthers JD, Carruthers A, Saad F, et al. Time course of the effects of a fixed-volume formulation of nonanimal stabilized hyaluronic acid gel for nasolabial fold correction. Dermatol Surg. 2010;36 Suppl 3:2153-2159.

Future Directions and Innovations in HA Research

Advancements in HA Formulations and Delivery Systems

Researchers and manufacturers continue to explore advancements in hyaluronic acid (HA) formulations and delivery systems to improve the efficacy, longevity, and patient experience of HA-based treatments.

Advances in HA formulations aim to optimize the rheological properties, viscoelasticity, and durability of HA fillers. Various crosslinking technologies, such as sequential crosslinking or combination with other compounds, have been investigated to enhance the stability and longevity of HA fillers. Additionally, modifications to HA molecular weight and concentration can influence the rheological behavior and tissue integration of fillers.

Furthermore, research is focused on developing innovative delivery systems that enable precise and controlled deposition of HA fillers. Novel injection techniques, such as cannulas or microcannulas, offer potential benefits such as reduced trauma, minimized bruising, and improved accuracy in filler placement. These advancements aim to enhance patient comfort, safety, and aesthetic outcomes.

Novel Applications and Emerging Technologies

In addition to traditional applications in aesthetic medicine, there is growing interest in exploring novel applications of HA in various medical fields.

One emerging area is the use of HA in regenerative medicine and tissue engineering. HA’s biocompatibility, biodegradability, and ability to modulate cell behavior make it a promising biomaterial for scaffold-based tissue engineering strategies. Researchers are investigating the potential of HA-based scaffolds in wound healing, tissue regeneration, and organ engineering.

Another emerging technology is the combination of HA with other agents or techniques to enhance treatment outcomes. For example, the synergistic effects of combining HA fillers with platelet-rich plasma (PRP) or adipose-derived stem cells are being explored to improve tissue regeneration and promote natural rejuvenation. Additionally, the use of HA as a carrier for growth factors or therapeutic agents is being investigated to enhance targeted drug delivery and tissue repair.

Research Areas for Further Investigation

While HA has been extensively studied and utilized in various medical and aesthetic applications, there are still several areas that warrant further investigation:

1. Long-term safety and efficacy: Continued research is needed to assess the long-term safety and efficacy of HA-based treatments, including the evaluation of potential risks, adverse effects, and tissue responses over extended periods of time.
2. Optimization of HA-based scaffolds: Further research is necessary to optimize the design and properties of HA-based scaffolds for tissue engineering applications. This includes refining the scaffold architecture, incorporating bioactive molecules, and enhancing cellular interactions for improved tissue regeneration.
3. Personalized treatment approaches: Investigating individual variations in HA metabolism, degradation rates, and tissue interactions can help develop personalized treatment approaches that account for patient-specific factors, leading to optimized outcomes and patient satisfaction.
4. Standardization and quality control: Establishing standardized protocols for HA production, characterization, and quality control is essential to ensure consistency and safety across different HA products and formulations.
5. Comparative studies: Comparative studies evaluating the efficacy, longevity, and patient satisfaction of different HA formulations, delivery systems, and injection techniques can provide valuable insights for treatment selection and optimization.

By addressing these research areas, further advancements in HA research can contribute to the development of more effective, safe, and personalized treatment options, expanding the scope of HA applications in both medical and aesthetic fields.

References:

1. Raspaldo H. Hyaluronic acid fillers: Science and clinical advances. Clin Plast Surg. 2016;43(3):527-534.
2. Kablik J, Monheit GD, Yu L, et al. Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg. 2009;35 Suppl 1:302-312.
3. Rosales AM, Williams CK. Hyaluronic acid-based nanomaterials for regenerative medicine. Chem Commun (Camb). 2011;47(28):7559-7578.
4. Signorini M, Liew S, Sundaram H, et al. Global aesthetics consensus: Hyaluronic acid fillers and botulinum toxin type A – recommendations for combined treatment and optimizing outcomes in diverse patient populations. Plast Reconstr Surg. 2016;137(5):1410-1423.
5. Wang F, Garza LA, Kang S, et al. Advances in wound healing therapies for chronic diabetic foot ulcers. Adv Drug Deliv Rev. 2018;129:350-365.
6. Segura T, Anderson BC, Chung PH, et al. Biomaterials and scaffolds for tissue engineering. Mater Today (Kidlington). 2013;16(11):477-485.

Hyaluronic Acid in Anti-Aging Therapy

Summary of Current Practices

Hyaluronic acid (HA) has become a versatile and widely used biomaterial in various medical and aesthetic applications. It offers numerous benefits, including biocompatibility, biodegradability, and the ability to restore volume, enhance tissue hydration, and stimulate collagen production. The use of HA fillers for facial rejuvenation, lip augmentation, and facial contouring has gained significant popularity. In ophthalmology, HA-based products have found utility in ocular lubrication and protection, while intra-articular HA injections have demonstrated efficacy in managing joint pain and osteoarthritis. Additionally, HA has shown promise in wound healing and tissue regeneration applications, acting as a scaffold for cellular proliferation and tissue repair.

Implications for Clinical Practice

The advancements in HA formulations, injection techniques, and treatment protocols have revolutionized clinical practice. Healthcare providers must remain up-to-date with the latest research and guidelines to ensure safe and effective treatment outcomes. Understanding the structure and function of HA, its mechanism of action, and its diverse medical applications is crucial for selecting appropriate products and tailoring treatment plans to individual patient needs. Furthermore, comprehensive patient assessment, including medical history, expectations, and informed consent, is vital for successful outcomes and patient satisfaction.

Recommendations for Future Research

Despite the extensive knowledge and successful implementation of HA in clinical practice, there are still areas that warrant further research:

1. Long-term safety and efficacy: Conducting long-term studies to evaluate the safety and durability of HA-based treatments will provide valuable insights into their long-lasting effects and potential complications.
2. Optimization of HA formulations: Exploring novel HA formulations, such as hybrid materials or combination therapies, can enhance the longevity, viscoelastic properties, and tissue integration of HA-based products.
3. Comparative studies: Conducting head-to-head comparative studies of different HA products, injection techniques, and treatment protocols will help identify the most effective and efficient approaches for specific indications.
4. Standardization and quality control: Establishing rigorous standards for HA production, characterization, and quality control will ensure consistency, safety, and efficacy across different products and manufacturers.
5. Patient-reported outcomes: Assessing patient satisfaction, quality of life, and long-term outcomes following HA treatments will provide insights into the psychological and emotional impacts of these interventions.
6. Personalized approaches: Investigating individual variations in HA metabolism, tissue interactions, and treatment responses will allow for personalized treatment plans tailored to each patient’s unique characteristics.

By addressing these research recommendations, the field of HA can continue to evolve, leading to improved treatment outcomes, increased patient satisfaction, and expanded applications across various medical specialties.

References:

1. de Boulle K, Heydenrych I. Patient factors influencing dermal filler complications: Prevention, assessment, and treatment. Clin Cosmet Investig Dermatol. 2015;8:205-214.
2. de Maio M, Swift A, Signorini M, et al. Facial assessment and injection guide for botulinum toxin and injectable hyaluronic acid fillers: Focus on the midface. Plast Reconstr Surg. 2017;140(3):540e-550e.
3. Humphrey S, Carruthers J, Carruthers A, et al. Refining the aesthetic results of the upper lip using a new approach to botulinum toxin injection. Dermatol Surg. 2019;45(2):292-299.
4. Klein AW, Cohen JL. Clinical application of fillers: Scientific background and practical considerations. J Am Acad Dermatol. 2008;58(5):803-814.
5. Sundaram H, Cassuto D. Biophysical characteristics of hyaluronic acid soft-tissue fillers and their relevance to aesthetic applications. Plast Reconstr Surg. 2013;132(4 Suppl 2):5S-21S.
6. Wang F, Garza LA, Kang S, et al. Advances in wound healing therapies for chronic diabetic foot ulcers. Adv Drug Deliv Rev. 2018;129:350-365.